|
Conditioning Regimens
|
|
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia
|
711
|
|
N Kröger, T Zabelina, S Sonnenberg, W Krüger, H Renges, N Stute, F Finkenstein, U Mayer, K Holstein, W Fiedler, H Colberg, R Sonnen, R Kuse, D Braumann, B Metzner, F del Valle, R Erttmann, H Kabisch & AR Zander
|
| Abstract Full Article PDF
|
 |
|
|
Progenitor Cell Mobilisation
|
|
A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF
|
717
|
|
L Meldgaard Knudsen, L Jensen, E Gaarsdal, K Nikolaisen & HE Johnsen
|
| Abstract Full Article PDF
|
| |
|
|
Peripheral Blood Stem Cells
|
|
Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation
|
723
|
|
JD Lickliter, PB McGlave, TE DeFor, JS Miller, NK Ramsay, CM Verfaillie, LJ Burns, JE Wagner, T Eastlund, K Dusenbery & DJ Weisdorf
|
| Abstract Full Article PDF
|
| |
|
|
Breast Cancer
|
|
Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer
|
729
|
|
DE Reece, KA Foon, M Bhattacharya-Chatterjee, GA Hale, DS Howard, RK Munn, R Nath, BA Plummer, A Teitelbaum & GL Phillips
|
| Abstract Full Article PDF
|
| |
|
|
Non-Hodgkin's Lymphoma
|
|
Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol
|
737
|
|
E Jantunen, E Mahlamäki & T Nousiainen
|
| Abstract Full Article PDF
|
| |
|
|
Immune Recovery
|
Lymphocyte subset reconstitution after HLA-identical placental blood transplantation (PBT) or PBT plus bone marrow transplantation (BMT) in three children with  -thalassemia major
|
743
|
|
A Vitucci, G Lucivero, F Locatelli, M Capocasale, N Tannoia & A Pietrapertosa
|
| Abstract Full Article PDF
|
| |
|
|
ABO Compatibility
|
|
Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components
|
749
|
|
SD Rowley, PS Liang & L Ulz
|
| Abstract Full Article PDF
|
| |
|
|
Infections Post-Transplant
|
|
Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients
|
759
|
|
E Jantunen, P Ruutu, A Piilonen, L Volin, T Parkkali & T Ruutu
|
| Abstract Full Article PDF
|
| |
|
|
Viral Infections
|
|
A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy
|
763
|
|
RK Avery, KA Adal, DL Longworth & BJ Bolwell
|
| Abstract Full Article PDF
|
| |
|
|
Donor Lymphocyte Infusions
|
|
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome
|
769
|
|
S Shiobara, S Nakao, M Ueda, H Yamazaki, S Takahashi, S Asano, H Yabe, S Kato, S Imoto, A Maruta, T Yoshida, H Gondo, Y Morishima & Y Kodera
|
| Abstract Full Article PDF
|
| |
|
|
Late Complications Post-SCT
|
|
Scintigraphic study of the major salivary glands in pediatric bone marrow transplant recipients
|
775
|
|
M Bågesund, S Richter, B gren, O Ringdén & G Dahllöf
|
| Abstract Full Article PDF
|
| |
|
|
Technical Reports
|
|
Permanent tunneled silicone central venous catheters for autologous PBPC harvest in children and young adults
|
781
|
|
G Fischmeister, V Witt, HA Zaunschirm, G Fritsch, P Höcker, U Pötschger, A Zoubek & H Gadner
|
| Abstract Full Article PDF
|
| |
|
Large scale purification of human blood CD34+ cells from cryopreserved peripheral blood stem cells, using a nylon-fiber syringe system and immunomagnetic microspheres
|
787
|
|
K Koizumi, M Nishio, T Endo, H Takashima, Y Haseyama, K Fujimoto, S Yamamoto, N Sato, K Ikebuchi, H Ikeda, T Koike & K Sawada
|
| Abstract Full Article PDF
|
| |
|
|
Case Reports
|
|
Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient
|
795
|
|
S Tauro, V Toh, H Osman & P Mahendra
|
| Abstract Full Article PDF
|
| |
|
Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells
|
797
|
|
MA Higman, JD Port, NJ Beauchamp Jr & AR Chen
|
| Abstract Full Article PDF
|
| |
|
Cyclosporin A-related cerebral vasculopathy
|
801
|
|
RM Shbarou, NJ Chao & JC Morgenlander
|
| Abstract Full Article PDF
|
| |
|
Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein–Barr virus infection
|
805
|
|
N Fujii, K Takenaka, A Hiraki, Y Maeda, K Ikeda, K Shinagawa, A Ashiba, M Munemasa, K Sunami, Y Hiramatsu, F Ishimaru, K Niiya, T Yoshino & M Harada
|
| Abstract Full Article PDF
|
| |
|
Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation
|
809
|
|
S Imoto, T Murayama, H Gomyo, I Mizuno, T Sugimoto, T Nakagawa & T Koizumi
|
| Abstract Full Article PDF
|
| |
|
Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors
|
811
|
|
W Hilbe, W Nussbaumer, H Bonatti, J Thaler, D Niederwieser & D Nachbaur
|
| Abstract Full Article PDF
|
| |
|
|
Correspondence
|
|
Trimethoprim/sulfamethoxazole prophylaxis impairs function of mobilised autologous peripheral blood stem cells
|
815
|
|
M Fuchs, C Scheid, A Schulz, V Diehl & D Söhngen
|
| Full Article PDF
|
| |
| |
| |
